Showing results (21-30 of 719) with videos related to
Sort By:
Pageof 72
Expert Opinion on Drug Discovery|October 3, 2025
The discovery and development of tisagenlecleucel for the treatment of adult patients with relapsed or refractory follicular lymphomaSmith Kungwankiattichai, Richard T MaziarzCurrent Oncology Reports|August 12, 2006
Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of imatinib treatment on remission induction and allogeneic stem cell transplantationTibor Kovacsovics, Richard T MaziarzCell Stem Cell|June 1, 2011
Hematopoietic stem cell transplantation and implications for cell therapy reimbursementRichard T Maziarz, Dawn DriscollMethods in Cell Biology|October 2, 2017
Rapid kinetic BRET measurements to monitor G protein activation by GPCR and non-GPCR proteinsMarcin Maziarz, Mikel Garcia-MarcosAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 3, 2004
Cost considerations in selecting coronary artery revascularization therapy in the elderlyDavid M Maziarz, Theodore C KoutlasBone Marrow Transplantation|August 28, 2003
Transplantation for chronic myelogenous leukemia: yes, no, maybe so. . . An Oregon perspectiveRichard T Maziarz, Michael J MauroBone Marrow Transplantation|December 1, 1994
Abscopal depression of G-CSF mobilized peripheral stem cellsM P Braun, R T MaziarzJournal of Molecular Biology|March 5, 1999
Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membraneJ Wang, K Maziarz, M RatnamAmerican Journal of Infection Control|May 28, 2017
Infection prevention outside of the acute care setting: Results from the MegaSurvey of infection preventionistsMonika Pogorzelska-Maziarz, Ericka L KalpMayo Clinic Proceedings|March 15, 2006
Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used?Michael J Mauro, Richard T MaziarzPageof 72